Showing results (1231-1240 of 2,949) with videos related to
Sort By:
Pageof 295
The Journal of Pharmacy and Pharmacology|July 24, 2024
PAMAM dendrimers as mediators of dermal and transdermal drug delivery: a reviewMelissa Kirkby, Akmal Hidayat Bin Sabri, Amy Holmes, et al.Plos One|August 15, 2014
Scaling-up access to antiretroviral therapy for children: a cohort study evaluating care and treatment at mobile and hospital-affiliated HIV clinics in rural ZambiaJanneke H van Dijk, William J Moss, Francis Hamangaba, et al.The Journal of Experimental Medicine|January 1, 1990
An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)S R Burrows, T B Sculley, I S Misko, et al.Proceedings of the National Academy of Sciences of the United States of America|March 16, 2000
Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298M Tesauro, W C Thompson, P Rogliani, et al.Acta Oncologica (Stockholm, Sweden)|February 9, 2000
A retrospective analysis of Hickman line-associated complications in patients with solid tumours undergoing infusional chemotherapyV J O'Neill, T R Jeffrey Evans, J Preston, et al.Injury|November 4, 2017
Complications of trans arterial embolization during the resuscitation of pelvic fracturesBoopalan Ramasamy, Dominic Thewlis, Mary J Moss, et al.Annals of Internal Medicine|January 1, 1981
The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosisN K Roberts, W R Cabeen, J Moss, et al.Journal of Cardiovascular Electrophysiology|July 8, 2015
Long-QT Syndrome and Therapy for Attention Deficit/Hyperactivity DisorderClaire Zhang, Valentina Kutyifa, Arthur J Moss, et al.The Journal of General Virology|February 1, 1991
Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3I S Misko, C Schmidt, D J Moss, et al.Clinical Chemistry|May 20, 2006
High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patientsJames P Corsetti, David L Rainwater, Arthur J Moss, et al.Pageof 295